PADOVA SARCOMA FORUMFocus on hot topics5 December 2018Centro Culturale San GaetanoPadova

Events srlProvider ECM n.1023Via Mantegna 1 – 60019 Senigallia (AN)Tel. 071 7930220 segreteria4@events-communication.com

Segreteria organizzativa / Provider ECM

FACULTYAglietta Massimo, CandioloAngelini Andrea, PadovaAntonello Michele, PadovaBassetto Franco, PadovaBiagini Roberto, RomaBonvalot Sylvie, ParigiBrunello Antonella, PadovaCasali Paolo Giovanni, MilanoCingarlini Sara, VeronaComandone Alessandro, TrevisoDe Paoli Antonino, AvianoDe Pas Tommaso, MilanoDei Tos Angelo Paolo, TrevisoFiore Marco, MilanoGrignani Giovanni, CandioloLonghi Alessandra, BolognaMontesco Maria Cristina, PadovaPennacchioli Elisabetta, MilanoQuagliuolo Vittorio Lorenzo, MilanoRastrelli Marco, PadovaRossi Carlo Riccardo, PadovaRuggieri Pietro, PadovaScarzello Giovanni, PadovaSiatis Dimitris, CandioloTropea Saveria, PadovaVincenzi Bruno, RomaVindigni Vincenzo, PadovaVitolo Viviana, PaviaZagonel Vittorina, Padova

REGISTRATIONLa partecipazione è libera e gratuita. Iscrizioni on-line sul sito:www.events-communication.net/sarcomi2018La Segreteria confermerà via e-mail le iscrizioni accettate fino ad esaurimento dei posti.

ECMIl Convegno partecipa al programma ECM con l’accreditamento delle seguenti figure professionali:medico chirurgo (tutte le professioni), farmacista territoriale e ospedaliero, biologo, tecnico sanitario di radiologia medica, psicologo, tecnico sanitario di laboratorio biomedico, fisioterapista, infermiere, dietista

PARTNERS

con il patrocinio di

V SESSIONVascular soft tissue sarcoma: local approach and systemic treatmentModerators R.Biagini - A. Comandoneore 14.55 Vascular lesions of soft tissue S. Cingarlini

ore 15.15 Role of surgery M. Fiore

ore 15.35 Conventional chemotherapy and targeted agents: hopes and hypes A. Longhi

ore 15.55 Discussion

VI SESSIONMetastatic DiseaseModerators P.G. Casali - V. Zagonelore 16.10 Surgery of oligometastasis in the skeleton A. Angelini

ore 16.30 Oligomestatic disease: challenging cases D. Siatis

ore 16.50 How many lines of systemic treatment? A. Brunello

ore 17.10 Discussion ore 17.30 Conclusions

PROGRAMMore 8.30 Registrazione dei partecipanti

I SESSIONLocally advanced disease in the extremities (neoadjuvant approach)Moderators A. De Paoli - C. R. Rossiore 9.00 Emerging radiation therapy modalities (proton therapy) V. Vitolo

ore 9.20 Role of nanoparticles and radiation therapy S. Bonvalot

ore 9.40 Role of Isolated Limb Perfusion S. Tropea

ore 10.00 Discussion

II SESSIONLocalized disease at difficult sitesModerators F. Bassetto - G. Scarzelloore 10.15 Resections of pelvic tumors P. Ruggieri

ore 10.35 Reconstruction: vascular techniques M. Antonello

ore 10.55 Reconstruction: nervous techniques V. Vindigni

ore 11.15 Discussion

III SESSIONRelapsed retroperitoneal sarcomaModerators E. Pennacchioli - V. Quagliuoloore 11.50 Histological subtype and pattern of recurrence A.P. Dei Tos

ore 12.10 When operate, and when to stop operating? M. Rastrelli

ore 12.30 Histotype-based systemic treatment G. Grignani

ore 12.50 Discussion ore 13.00 Lunch

IV SESSIONDesmoid-type fibromatosis: changes in the approach to the diseaseModerators M. Aglietta - T. De Pasore 14.00 When is a neoplasm not a neoplasm? When it is a desmoid M. C. Montesco

ore 14.20 To treat or not treat: that is the question B. Vincenzi

ore 14.40 Discussion

Sarcomas are a group of rare cancers, comprising over 70 different subtypes, with an inci-dence of about 5 cases/100,000 inhabitants per year. The heterogeneity and rarity of sar-comas explains the need for a diagnostic-therapeutic framework that can differ depending on the site of onset, the mode of presentation, the possible histotype and other conditions related to the patient. The sarcoma patient requires a multidisciplinary approach, with collaboration among the different specialists who intervene in the care path of the patient, from the diagnosis to the choice of therapeutic strategy. In recent years, new clinical prac-tices have been introduced with regard to the diagnostic process and a number of innova-tive drugs have become available. Despite a number of new findings, there are still many areas of discussion and controversy related to the complexity and heterogeneity of these neoplasms. This event aims to be an opportunity to provide an update for all specialists involved in the management of patients with sarcoma and facilitate an open discussion.

SCIENTIFIC COMMITTEEProf. Carlo Riccardo Rossi Direttore U.O.C. Chirurgia Oncologia, IOV-IRCCS, Università di Padova

Prof. Pietro Ruggieri Direttore Clinica Ortopedica, Azienda Ospedaliera, Università di Padova

Dr.ssa Vittorina Zagonel Direttore Dipartimento di Oncologia Clinica e Sperimentale, Direttore U.O.C. Oncologia Medica 1, IOV-IRCCS, Padova

SCIENTIFIC SECRETARIATA. Angelini, A. Brunello, M. Rastrelli, S. Tropea

SEDE Centro Culturale San Gaetano - Padova